Multiplex PCR identification of eight clinically relevant Candida species

dc.contributor.authorCarvalho, Agostinhopor
dc.contributor.authorOliveira, Sofia Costa depor
dc.contributor.authorMartins, M. L.por
dc.contributor.authorPina-Vaz, C.por
dc.contributor.authorRodrigues, A. G.por
dc.contributor.authorLudovico, Paulapor
dc.contributor.authorRodrigues, Fernando José dos Santospor
dc.date.accessioned2020-10-26T10:33:45Z
dc.date.available2020-10-26T10:33:45Z
dc.date.issued2007-11
dc.description.abstractInvasive fungal infections, specifically candidemia, constitute major public health problems with high mortality rates. Therefore, in the last few years, the development of novel diagnostic methods has been considered a critical issue. Herein we describe a multiplex PCR strategy allowing the identification of 8 clinically relevant yeasts of the Candida genus, namely C. albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C. guilliermondii, C. lusitaniae and C. dubliniensis. This method is based on the amplification of two fragments from the ITS1 and ITS2 regions by the combination of 2 yeast-specific and 8 species-specific primers in a single PCR reaction. Results from the identification of 231 clinical isolates are presented pointing to the high specificity of this procedure. Furthermore, several Candida isolates were identified directly from clinical specimens which also attests to the method's direct laboratory application. The results from the multiplex reactions with other microorganisms that usually co-infect patients also confirmed its high specificity in the identification of Candida species. Moreover, this method is simple and presents a sensitivity of approximately 2 cells per ml within 5 hours. Furthermore, it allows discrimination of individual Candida species within polyfungal samples. This novel method may therefore provide a clinical diagnostic procedure with direct applicability.por
dc.description.sponsorshipAgostinho Carvalho was financially supported by a fellowship from Fundação para a Ciência e Tecnologia, Portugal (contract SFRH/BD/11837/2003). This study was supported by Fundação para a Ciência e Tecnologia, Portugal (POCI/SAU-ESP/61080/2004).por
dc.distributioninternationalpor
dc.identifier.doi10.1080/13693780701501787por
dc.identifier.eissn1460-2709
dc.identifier.issn1369-3786
dc.identifier.pmid17885953por
dc.identifier.urihttps://hdl.handle.net/1822/67702
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherOxford University Presspor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F11837%2F2003/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/POCI/61080/PTpor
dc.rightsopenAccesspor
dc.subjectCandidapor
dc.subjectCandidiasispor
dc.subjectDNA Primerspor
dc.subjectDNA, Ribosomal Spacerpor
dc.subjectHumanspor
dc.subjectPolymerase Chain Reactionpor
dc.subjectSensitivity and Specificitypor
dc.subjectCandidemiapor
dc.subjectDiagnosticpor
dc.subjectIdentificationpor
dc.subjectPCRpor
dc.subjectMultiplexpor
dc.subject.wosScience & Technologypor
dc.titleMultiplex PCR identification of eight clinically relevant Candida speciespor
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationEndPage627por
oaire.citationIssue7por
oaire.citationStartPage619por
oaire.citationVolume45por
sdum.journalMedical Mycologypor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
Carvalho-2007-Multiplex-pcr-identification-of-eig.pdf
Tamanho:
209.95 KB
Formato:
Adobe Portable Document Format